These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Position paper on allergen immunotherapy. Report of a BSACI working party. January-October 1992. Clin Exp Allergy; 1993 Aug; 23 Suppl 3():1-44. PubMed ID: 8258111 [No Abstract] [Full Text] [Related]
23. [Considerations on allergy in rural environments]. Bregevin B; Favennec F; Vallet G Presse Therm Clim; 1970; 107(4):209-15. PubMed ID: 5537404 [No Abstract] [Full Text] [Related]
24. [Mechanisms of action of specific hyposensitizing therapy and immunotherapy]. Ricci M Folia Allergol (Roma); 1970; 17(3):245-52. PubMed ID: 4102840 [No Abstract] [Full Text] [Related]
25. [Immunotherapy of allergic diseases: present and future]. Müller U Schweiz Med Wochenschr; 1983 Dec; 113(52):1982-8. PubMed ID: 6229874 [TBL] [Abstract][Full Text] [Related]
26. Effect of hyposensitization for tree pollinosis on associated apple allergy. Herrmann D; Henzgen M; Frank E; Rudeschko O; Jäger L J Investig Allergol Clin Immunol; 1995; 5(5):259-67. PubMed ID: 8574432 [TBL] [Abstract][Full Text] [Related]
27. Allergy practice in retrospect and in prospect. Tuft L Ann Allergy; 1976 Jul; 37(1):58-66. PubMed ID: 782301 [No Abstract] [Full Text] [Related]
28. Safety of sublingual immunotherapy with a monomeric allergoid in very young children. Agostinis F; Tellarini L; Canonica GW; Falagiani P; Passalacqua G Allergy; 2005 Jan; 60(1):133. PubMed ID: 15575951 [No Abstract] [Full Text] [Related]
29. Allergy versus clinical immunology: a critical analysis. Swineford O Ann Allergy; 1974 Dec; 33(6):337-43. PubMed ID: 4613212 [No Abstract] [Full Text] [Related]
31. [Applicable strategies for the mucosal immune system in the regulation of allergic diseases]. Kurashima Y; Kunisawa J; Kiyono H Arerugi; 2008 Feb; 57(2):87-94. PubMed ID: 18349582 [No Abstract] [Full Text] [Related]
32. [Allergen specific-IgG4 in circulating immune complexes in patients with inhalant allergy undergoing specific immunotherapy]. Rogala B; Jarzab J; Rymarczyk B; Tłuczykont B Wiad Lek; 2004; 57(3-4):123-30. PubMed ID: 15307518 [TBL] [Abstract][Full Text] [Related]
33. [Special aspects of immunotherapy in children]. Ruëff F J Dtsch Dermatol Ges; 2006 Feb; 4(2):143-52; quiz 153-4. PubMed ID: 16503943 [No Abstract] [Full Text] [Related]
34. Oral allergy syndrome in patients with airborne pollen allergy treated with specific immunotherapy. Czarnecka-Operacz M; Jenerowicz D; Silny W Acta Dermatovenerol Croat; 2008; 16(1):19-24. PubMed ID: 18358104 [TBL] [Abstract][Full Text] [Related]
35. A history of pollen mapping and surveillance: the relations between natural history and clinical allergy. Mitman G J Allergy Clin Immunol; 2004 Nov; 114(5):1230-5. PubMed ID: 15536439 [No Abstract] [Full Text] [Related]
36. [Retrospect and perspective in rhinologic allergology]. Zenner HP HNO; 1987 Aug; 35(8):315-7. PubMed ID: 3308794 [TBL] [Abstract][Full Text] [Related]